Gone are the days of little guidance for weight gain during pregnancy, but determining the best weight range has been elusive. A new study provides some helpful advice.
The days of “eating for 2” and seeing pregnancy as a time to not worry about calorie consumption has changed as more knowledge about the impact of weight gain on the mother has become available. The potential link between gestational weight gain and infant morbidity and mortality remains unclear. A recent report sought to identify optimal gestational weight gain ranges that are linked with a reduced risk of infant morbidity and mortality.1
The report’s investigators linked birth and infant death data between 2011 and 2015 to look for association of gestational weight gain with infant morbidity and mortality. Their 2 main outcomes were significant morbidity, which was defined as seizures, antibiotic therapy, surfactant therapy, admission to the neonatal intensive care unit, and any assisted ventilation; as well as infant mortality at younger than 1 year of age, which was split into (<1 hour, 1-23 hours, 1-6 days, 7-27 days, or 28-365 days after birth
There were 15,759,945 mother/child pairs included in the study. Mothers had an average age of 28.1 years and gained 14.1 kg during pregnancy. The average gestational weight gain decreased with body mass index category: underweight, 15.7 [6.4] kg; normal weight, 15.4 [6.2] kg; overweight, 14.2 [7.4] kg; obesity class 1, 12.2 [8.0] kg; obesity class 2, 10.3 [8.4] kg; obesity class 3, 8.2 [9.2] kg; P < .001. In this cohort, 8.8% of the newborns had significant morbidity, with the lowest prevalence occurring in infant born to women in the normal weight body mass index class and the highest in infant born to women with class 3 obesity. Additionally, 0.34% of infants died within a year of birth, with the highest rate occurring in infants with mothers who had class 3 obesity and the lowest found in infants born to mothers with a normal weight body mass index class. Investigators determined that optimal gestational weight gain ranges were 12.0 to less than 24.0 kg for underweight and normal weight women, 10.0 to less than 20.0 kg for overweight women, 8.0 to less than 16.0 kg for women with class 1 obesity, 6.0 to less than 16.0 kg for class 2 obesity, and 6.0 to less than 10.0 kg for class 3 obesity. They noted that the lower bounds of the ranges were higher than existing recommendations for overweight women and those with class 1-3 obesity.
They concluded that extremes of gestational weight gain were tied to an increased risk of negative outcomes for the infant, which held across all body mass index categories. They believe that this indicated that weight maintenance and loss should not be used for routine guidelines.
This article was initially published by our sister publication Contemporary Pediatrics.
Reference
1. Wang L, Zhang X, Chen T, et al. Association of gestational weight gain with infant morbidity and mortality in the United States. JAMA Netw Open. 2021;4(12):e2141498. doi:10.1001/jamanetworkopen.2021.41498
Study shows a healthy prenatal diet could be upstream obesity prevention strategy
December 26th 2024"Our findings support the recommendation of a healthy diet based on the current guidelines (as measured by the HEI) during pregnancy, since it may reduce patterns of infant growth outside reference ranges."
Read More
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More